MedPath

Clinical Study of the HeartLight X3 Endoscopic Ablation System With Excalibur Balloon

Not Applicable
Completed
Conditions
Atrial Fibrillation
Interventions
Device: HeartLight X3
Registration Number
NCT03470636
Lead Sponsor
CardioFocus
Brief Summary

The objective of the study is to demonstrate the improved ablation and procedure times of the HeartLight X3 compared to the current HeartLight catheter in the treatment of atrial fibrillation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • paroxysmal atrial fibrillation failure of at least one AAD others
Exclusion Criteria
  • overall good health as established by multiple criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
HeartLight X3HeartLight X3Pulmonary vein isolation using HeartLight X3
Primary Outcome Measures
NameTimeMethod
Ablation timeAcute - at the end of the index procedure

Ablation time

Secondary Outcome Measures
NameTimeMethod
Procedure timeAcute - at the end of the index procedure

Procedure time

PV IsolationAcute - at the end of the index procedure

Percent of isolated pulmonary veins

PAE Rate30 Days

Primary Adverse Event rate

AF Free Rate6 and 12 months

6- and 12-month chronic results

Trial Locations

Locations (1)

Nemocnice Na Homolce

🇨🇿

Prague, Czechia

© Copyright 2025. All Rights Reserved by MedPath